CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Down 93.6% in April
by Doug Wharley · The Cerbat GemCBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 399,666 shares, a decrease of 93.6% from the April 15th total of 6,209,240 shares. Based on an average trading volume of 109,899,084 shares, the days-to-cover ratio is presently 0.0 days.
CBD Life Sciences Stock Up 33.3%
Shares of OTCMKTS CBDL traded up $0.00 on Monday, reaching $0.00. 1,938,518 shares of the company traded hands, compared to its average volume of 21,424,105. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.